BRIEF

on Form Bio

Form Bio Unveils Integration of Google Cloud AI Models on its Bioinformatics Platform

Form Bio, a leading computational life sciences solutions provider, announced the integration of Google Cloud's AI-based models for healthcare and life sciences research into its bioinformatics platform. This integration, facilitated through Form Bio's status as a Google Cloud Premier Partner, enables point-and-click access to Google Cloud's Vertex AI-based omics models. These models, renowned for their capabilities in analyzing large biological datasets, are now available on the Google Cloud Marketplace, streamlining the process for life sciences professionals to leverage these advanced tools on a trusted infrastructure.

Among the AI-powered omics models introduced are DeepVariant, DeepSomatic, DeepTrio, DeepVariant for RNA-seq, DeepConsensus, DeepPolisher, and AlphaFold Protein Structure Prediction. These offerings aim to significantly reduce the time and effort required by scientists in computational research, enhancing the pace at which scientific insights can be derived from omics data. Form Bio's platform is designed to be user-friendly, supporting non-technical users in managing data, executing workflows, and fostering collaborative research endeavors in drug discovery, synthetic biology, and genetic engineering.

Dai Vu, Managing Director of Marketplace & ISV GTM Programs at Google Cloud, commented on the collaboration, emphasizing the benefits for life science professionals in deploying omics models rapidly and securely on Google Cloud's infrastructure. This partnership underscores both companies' commitment to accelerating digital transformation within the life sciences sector.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Form Bio news